In an announcement published on 21 May 2026, Eli Lilly shared the results of the TRIUMPH-1 study, which involved 2,339 participants who were randomised to receive either retatrutide 4mg, 9mg, 12mg (building up every four weeks from 2mg), or placebo
If youre considering a non-surgical facelift to address sagging jowls, double chin, or nasolabial folds, book a consultation in one of our clinics in Essex and London Holborn & Harley Street with our Medical Director Dr Liakas to determine if Endolift is the right choice for you
GRAs reverse GLP-1(936)s glucagonostatic effect We used REMD2.59, a human monoclonal antibody and competitive GRA [43, 44] that does not bind to GLP-1Rs [45], to inactivate the GCGRs
Clin Pharmacol Ther 101:763772 [DOI] [PMC free article] [PubMed] 38.Zhou K, Donnelly LA, Kimber CH, et al